Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
AR2
Showing 0 of 4 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, Farallon Capital Management held 8,500,000 shares of AR2 (Array Biopharma), worth $393.8M. Farallon Capital Management's 13F filings listed AR2 from Q4 2018 to Q2 2019, 3 quarterly filings. AR2 was 2.6% of Farallon Capital Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.